Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy
NCT02911025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2021-02-08
Summary
The purpose of this study is to monitor the effect of Clobazam on sleep and daytime alertness in people with Epilepsy.
Conditions
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Principal Investigators
-
Milena Pavlova, MD · Brigham and Women's Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
Clobazam in Subjects With Lennox-Gastaut Syndrome
NCT00162981 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
NCT02565108 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy
NCT01932502 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot Study of Topiramate in Childhood Absence Epilepsy
NCT00210574 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
NCT02564952 ·Status: COMPLETED ·Phase: PHASE2
-
Physiologic Effects of Topiramate on Cognition
NCT02884050 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy
NCT01296880 ·Status: COMPLETED
-
Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome
NCT01160770 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093
NCT02171234 ·Status: COMPLETED ·Phase: PHASE1
-
Clobazam Use in Epilepsia Partialis Continua - Pilot Study
NCT02134366 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
NCT00297349 ·Status: COMPLETED
-
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118962 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy
NCT01190098 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy
NCT00266591 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older
NCT01465997 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults
NCT02912364 ·Status: COMPLETED ·Phase: PHASE4
-
To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
NCT00552305 ·Status: COMPLETED ·Phase: PHASE2
-
Cenobamate in the Intensive Care Unit
NCT06352723 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy
NCT00297323 ·Status: COMPLETED
-
An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.
NCT02316847 ·Status: TERMINATED ·Phase: PHASE2
-
A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
NCT02171195 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118949 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
NCT06453213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
NCT00522275 ·Status: COMPLETED ·Phase: PHASE3
-
Adherence to Pharmacological Antiepileptic Treatment in Adolescence
NCT05825807 ·Status: UNKNOWN